Lung Cancer Market - Trends Forecast Till 2028

Lung Cancer Market, By Drugs (Non-Small Cell Lung Cancer Drugs, Small Cell Lung Cancer Drugs), Phase (Phase I, Phase II, Phase III, Phase IV), Test (Imaging Tests, Sputum Cytology, Biopsy, Others), Surgery Procedures (Segmental Resection, Wedge Resection, Lobectomy, Pneumonectomy, Video-Assisted Thoracoscopic Surgery, Thoracic Surgery, Others), Therapy (Targeted Therapy, Radiation Therapy, Chemotherapy, Immunotherapy, Chemoradiotherapy, Stereotactic Radiation Therapy, Photodynamic Therapy, Others), End Users (Oncology Centers, Hospitals, Specialty Centers, Academic Research Institutes And Laboratories, Others), Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: September, 2020

Base Year Estimate: 2019

Report ID: D-HC-LCM-41

Format:  

Number of Pages: 162

Domain: Healthcare

Lung Cancer Market – Trends Forecast Till 2028

The global lung cancer market is anticipated to reach USD 50.14 billion by 2020 growing at a CAGR of 12.4% during the forecasting period, 2020-2028. Lung cancer is an uncontrolled growth of abnormal cells either in the single lung or both the lungs and these abnormal cells do not carry out the functions of normal lung cells and do not develop into healthy lung tissue. Factors such as the rising rate of lung cancer patients globally and rising smoking & air pollution globally leading to cause lung cancer are some of the major drivers for the lung cancer market

Lung Cancer Market – Trends Forecast Till 2028

Global lung cancer market is segmented into drugs, phase, test, surgery procedures, therapy, end-user, and geography.

Drugs segment is segmented into Non-Small Cell Lung Cancer Drugs and Small Cell Lung Cancer Drugs. Small Cell Lung Cancer Drugs are further segmented into Angiogenesis Inhibitor, Epidermal Growth Factor Receptor Blocker, Kinase Inhibitor, Microtubule Stabilizer, Folate Antimetabolites, PD-1/ PD-L1 Inhibitor. Small Cell Lung Cancer Drugs is further segmented into Doxorubicin Hydrochloride, Doxorubicin Hydrochloride, Etopophos (Etoposide Phosphate), Etoposide, Hycamtin (Topotecan Hydrochloride), Mechlorethamine Hydrochloride, Methotrexate, Mustargen (Mechlorethamine Hydrochloride), Nivolumab, Opdivo (Nivolumab), Trexall (Methotrexate), Topotecan Hydrochloride and Everolimus.

Phase segment is segmented into Phase I, Phase II, Phase III, and Phase IV

Test segment is segmented into Imaging Tests, Sputum Cytology, Biopsy, Others. A biopsy is further segmented into Bronchoscopy and Mediastinoscopy.

Surgery Procedures segment is segmented into Segmental Resection, Wedge Resection, Lobectomy, Pneumonectomy, Video-Assisted Thoracoscopic Surgery, Thoracic Surgery, and Others

Therapy segment is segmented into Targeted Therapy, Radiation Therapy, Chemotherapy, Immunotherapy, Chemoradiotherapy, Stereotactic Radiation Therapy, Photodynamic Therapy, and Others

End Users segment is segmented into Oncology Centers, Hospitals, Specialty Centers, Academic Research Institutes and Laboratories and Others

Geographically, the global lung cancer market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions 

North America region is the largest contributor to the lung cancer market in the forecast period 2020-2028 and the Asia-Pacific region is expected to grow with the highest CAGR during the forecast period 2020-2028.

Key players in the global lung cancer market are Kindred Healthcare, National Lung cancer, and Palliative Care Organization, Alzheimer’s Association, Benton Lung cancer Services, Oklahoma Lung cancer Care, New Hampshire Lung cancer and Palliative Care Organization, Dierksen Lung cancer, Covenant Care, Chatham-Kent Lung cancer, PruittHealth, Fairview Health Services and among others

The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:

  • In 2018, Loxo Oncology has received a breakthrough therapy designation from the FDA for its treatment of patients with RET fusion-positive non&ndash small cell lung cancer (NSCLC) or RET-mutant medullary thyroid cancer (MTC)
  • In 2018, researchers at the Indian Institute of Technology, Bombay have announced a newly developed platform that can help in the detection of lung cancer from breath. 

Hence, tremendous progress has been made over the last decade, and yet a lot more to come in recent years.

Available Customizations

In addition to the market data for the lung cancer market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirements.

Research Methodology

Secondary Research

This research method involved the usage of extensive secondary sources (such as directories and databases)—Hoovers, Avention, annual reports, investor presentation, a conference like Jefferies conference)—to identify and collect information useful for this study of the lung cancer market. The purpose of secondary research is to identify and collection of extensive, technical, market-oriented, and commercial studies of the global lung cancer market. Through secondary, the market is classified and segmented as per industry trends, developments, regional markets, products, and technological developments. 

Primary Research

The primary sources mainly included several industry experts from the core and related industries and suppliers, manufacturers, distributors, alliances, and organizations related to all segments of this industry’s supply chain. In-depth interviews were conducted with various primary respondents—including key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts—to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following figure depicts the market research methodology used in drafting this report on the lung cancer market.

The primary respondent breakdown is provided below:

Lung Cancer Market – Trends Forecast Till 2028

Market Sizing

Top-down and bottom approaches were used to derive the market estimate and validate the total revenue of the lung cancer market. This approach has also been used to derive the market for segmentation and sub-segmentation. 

Data Validation

Impact analysis has been conducted for deriving the market size. After collecting the in-depth quantitative and qualitative data, we contact the primary respondents in order to gain a 98.8% of confidence level on our data.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors
  • Gain authentic and granular data access for the lung cancer market so as to understand the trends and the factors involved in changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Features

Description

Market Revenue In 2020

USD 50.14 billion

Growth Rate

CAGR of 12.4% during the forecasting period, 2020-2028

Historical Data

2017-2018

Forecast Years

2020-2028

Base Year 

2019

Units Considered

Revenue in USD billion and CAGR from 2020 to 2028

Report Segmentation

Drugs, Phase, Test, Surgery Procedures, Therapy, End-User and Geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and the Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Kindred Healthcare, National Lung cancer, and Palliative Care Organization, Alzheimer’s Association, Benton Lung cancer Services, Oklahoma Lung cancer Care, New Hampshire Lung cancer and Palliative Care Organization, Dierksen Lung cancer, Covenant Care, Chatham-Kent Lung cancer, PruittHealth, Fairview Health Services and among others

Available Customization 

In addition to the market data for the lung cancer market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.